To recover your password please fill in your email address
Please fill in below form to create an account with us
Phase III trial of addition of adjuvant chemotherapy to standard chemoradiation as primary treatment for cervical cancer
See ANZCTR for full trial details >
|
Trial Summary: |
The OUTBACK trial is designed for patients with locally advanced cervical cancer suitable for primary treatment with chemoradiation. Its aim is to determine whether addition of adjuvant chemotherapy to standard cisplatin-based chemoradiation improves overall survival. |
|
Supported By: |
NHMRC Project Grant, Hospira |
|
Eligibility: |
Women with locally advanced cervix cancer |
|
Registration ID: |
ACTRN12610000732088 |
|
Participation: |
International |
|
Australian Lead Group: |
ANZGOG |
|
Status: |
Completed |
|
Activation Date: |
10/03/2011 |
|
Chairs: |
Prof Linda Mileshkin (Australia and New Zealand) |
|
Contact: |